Holmium Laser Lithotripsy for Urinary Calculi: A Retrospective Analysis from a Tertiary Hospital in Abuja, Nigeria
Main Article Content
Keywords
Holmium laser, Lithotripsy, Urolithiasis, Kidney, Ureter
Abstract
Background: Over the last decade, Holmium: YAG (Ho: YAG) laser has emerged as the gold standard for the intracorporeal treatment of urinary tract calculi. However, this technology is not readily available in most public-owned hospitals in Nigeria. This study aims to retrospectively document our experience with the efficacy and safety of Ho: YAG laser lithotripsy for urinary calculi at the Federal Medical Centre, Abuja.
Methodology: We reviewed all patients who underwent laser lithotripsy at FMC Abuja from April 2021 to October 2025. We deployed 600 μm, 365 μm, and 272 μm fibers with power settings of 50W, 10W, and 20W, respectively, for the lithotripsy of bladder, ureteral, and renal stones. Data recorded include the size, density, location of the stone, and clinical presentations and outcomes.
Results: A total of 111 patients underwent laser lithotripsy during the study period. Ages ranged from 18 to 67 years, with a mean age of 40.28 ± 12.3 years. The male-to-female ratio was 2:1. Of the patients, 45 (40.5%) had ureteral stones, 38 (34.2%) had renal stones, 17 (15.3%) had bladder stones, and 8 (7.2%) presented with calculi in both the kidney and ureter. Flank pain was the most common presentation (n = 62, 55.9%). Right-sided stones were predominant (n=49, 44.1%), while 18 (16.2%) had bilateral stones. The mean stone density was 968.68 HU (range: 566 - 1502). The mean post-operative hospital stay was 2.61 ± 1.34 days, with a stone clearance rate of 90.1%. Postoperative complications included fever (n=16, 14.4%), stent pain (n =3, 2.7%), and ureteric perforation (n=1, 0.01%).
Conclusion: The Holmium laser is a safe and effective modality for lithotripsy in our setting, associated with minimal postoperative complications. Further data will be necessary to substantiate this conclusion.
References
2. Scales CD, Smith AC, Hanley JM, Saigal CS., Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160-5. [PMC free article] [PubMed] [Reference list]
3. Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. Epidemiology of stone disease across the world. World J Urol 2017; 35:1301–20.
4. Routh, J. C., et al. (2018). Epidemiology of urolithiasis in children: a prospective cohort study. The Journal of Urology, 199(5), 1169-1174
5. Jung, J. H., Wulfers, C., & Atan, A. The evolution of laser technology for urolithiasis treatment. World Journal of Urology, 2020;38(5), 1077-1085.
6. Courcelle, A., Thiounn, N., & Traxer, O. Epidemiology, pathophysiology, and dietary treatment of kidney stones. Current Opinion in Urology, 2016; 26(3), 215-220
7. Omisanjo O, Bioku M, Williams O, Akinola O, Balogun F, Ikuerowo S. A 5-year review of presentation and management of urolithiasis in a Nigerian Teaching Hospital. J Surgery 2019;7: 143–7.
8. Abubakar BM, Abubakar A, Suleiman IE, Makama BS, Abdulhafeez AA, Gashua MG. Pattern of presentation and management of urolithiasis at federal medical centre, Nguru, Nigeria. Bo Med J 2017; 14:63–70.
9. Adetayo FO, Saanu OO, Osegbe DN. Chemical composition of urinary of urinary calculi in Nigerians. Nig Q J Hosp Med 2004; 14:143–6.
10. Romero V, Akpinar H, Assimos DG. Kidney stones: A global picture of prevalence, incidence, and associated risk factors. Rev Urol 2010;12: e86–96.
11. Mbadiwe, OM1; Onuh, AC2,3; Anyimba, SK1; Amu, OC1; Nnabugwu, II1. Urinary Stone Disease in Southeast Nigeria: Current Trends in Prevalence and Distribution. Nigerian Journal of Clinical Practice,2025; 28(3):p 320-324, DOI: 10.4103/njcp.njcp_311_24
12. Mbaeri TU, Amos Onu O, Odo C, Victor Nwadi U. Ureteroscopy and Holmium:YAG Laser Lithotripsy For Upper Tract Stones in a New Urology Centre: Our Initial Experience. Niger Med J. 2023; 64(2):259-266. PMID: 38898971; PMCID: PMC11185812.
13. Akpayak, Idorenyin Cletus1; Ikeh, Chukwudum Dennis1. Outcome of Flexible Ureteroscopy and Holmium Laser Lithotripsy in the Management of Renal Stones: A two-year Retrospective Study. Nigerian Journal of Medicine, 2023; 32(3):p 275-279. DOI: 10.4103/NJM.NJM_43_23
14. Razvi HA, Denstedt JD, Chun SS, Sales JL. Intracorporeal lithotripsy with the holmium:YAG laser. J Urol. 1996;156(3):912-4. PMID: 8709362
15. Kokaj, A.; Kamberi, H.; Kadrija, M. Investigation of ablation mechanism for laser-based lithotripsy. Romanian Med J. 2025, 72, 66–72, https://doi.org/10.37897/rmj.2025.1.14
16. Wright AE, Rukin NJ, Somani BK. Ureteroscopy and stones: Current status and future expectations. World J Nephrol 2014; 3:243–248.
17. Akram M, Cerrato C, Enikeev D, Tokas T, Somani BK. Safety and efficacy of laser lithotripsy for treatment of bladder calculi: evidence from a systematic literature review. Curr Opin Urol. 2025; 35(4):331-337. doi: 10.1097/MOU.0000000000001250. Epub 2024 Nov 13. PMID: 39774916
18. Ilker Y, Ozgür A, Yazici C. Treatment of ureteral stones using Holmium:YAG laser. Int Urol Nephrol. 2005;37(1):31-4. doi: 10.1007/s11255-004-6084-3. PMID: 16132755
19. Pishchalnikov YA, Behnke-Parks WM, Stoller ML. Plasma formation in holmium:YAG laser lithotripsy. Lasers Surg Med. 2023;55(5):503-514. doi: 10.1002/lsm.23659. Epub 2023 Mar 30. PMID: 36994818.
20. Hardy, L.A., Vinnichenko, V. and Fried, N.M. High power holmium:YAG versus thulium fiber laser treatment of kidney stones in dusting mode: ablation rate and fragment size studies. Lasers Surg. Med.2019; 51: 522-530. https://doi.org/10.1002/lsm.23057
21. Karakoyunlu N, Çakıcı MÇ, Sarı S, Hepşen E, Bikirov M, Kısa E, Özbal S, Özok HU, Ersoy H. Efficacy of various laser devices on lithotripsy in retrograde intrarenal surgery used to treat 1-2 cm kidney stones: A prospective randomized study. Int J Clin Pract. 2021;75(8):e14216. doi: 10.1111/ijcp.14216. Epub 2021 Apr 24. PMID: 33864337
22. Yao W, Wei X, Jing Q, Yuan X, Liu F, Zhang X (2025) Epidemiological trends of urolithiasis in working-age populations: Findings from the global burden of disease study 1990–2021. PLoS One 20(7): e0327343. https://doi.org/10.1371/journal.pone.0327343
23. Mizuno, Y., Nakashima, J., & Sakai, I. Epidemiology of urinary stone disease in Japan. Korean Journal of Urology, 2018;59(11), 726-731.
24. Zheng J, Zhang Q, Zhang J, Yao Y, Chen L, Liu Y, Song Y, Lin T, He G. Trends and sex disparities in the burden of urolithiasis in 204 countries and territories, 1990-2021. Chin Med J (Engl). 2025 Aug 20;138(16):1973-1983. doi: 10.1097/CM9.0000000000003622. Epub 2025 Jul 17. PMID: 40671190; PMCID: PMC12369707
25. Kirkali, Z., Tipton, K. C., & Bostwick, D. G. Urological disorders: a comparison between genders. The Journal of Urology, 2008; 179(5), 1845-1850.
26. Tiselius, H. G. Clinical effectiveness of urinary stone treatments. European Urology,2004; 45(1), 27-34.
27. Bryant M, Angell J, Tu H, Goodman M, Pattaras J, Ogan K. Health Related Quality of Life for Stone Formers. Journal of Urology [Internet]. 2012 Aug 1 [cited 2025 Dec 28];188(2):436–40. Available from: https://doi.org/10.1016/j.juro.2012.04.015
28. Miller, J. M., Kocher, N. J., & Stoller, M. L. Ureteroscopy for the treatment of ureteral stones: Update and insights. Urology,2016; 97, 35-42.
29. Ehren, I., Papadopoulos, A. A., Geavlete, P., & Karpouzis, L. The impact of stone density on treatment success in patients undergoing ureteroscopy. Journal of Endourology,2016; 30(9), 959-964.
30. Cocuzza M, Colombo JR Jr, Cocuzza AL, Mascarenhas F, Vicentini F, Mazzuchi E et al. Outcomes
of flexible ureteroscopic lithotripsy with holmium laser for upper urinary tract calculi. Int. Braz J
Urol. 2008; 34:143-149.
31. Hatipoğlu NK, Bodakci MN, Penbegül N, Soylemez H, Sancaktutar AA, Atar M etal. Our
experiences on retrograde intrarenal surgery. Dicle Tıp Dergisi 2014; 41:95-98.
32. Rassweiler, J. J., te, C., & Ceballos, L. Laser lithotripsy. Journal of Urology,2011; 185(3), 583-590.
33. Yan Z, Xie G, Yuan H, Cheng Y. Modular flexible ureteroscopy and holmium laser lithotripsy for the treatment of renal and proximal ureteral calculi: A single-surgeon experience of 382 cases. Exp Ther Med. 2015; 10:1467-1471.
34. Mobley, T. R., Ali, M. A., & Peters, J. A. Perioperative management in urolithiasis: A review of contemporary practices. World Journal of Urology,2017; 35(7), 975-981.
35. Lee, J. J., Hwang, J. H., & Ko, T. J. Complications of ureteroscopy: Prevention and management. Korean Journal of Urology,2015; 56(5), 340-345.
36. Abdelrahim AF, Abdelmaguid A, Abuzeid H, Amin M, Mousa el-S, Abdelrahim F. Rigid
ureteroscopy for ureteral stones: factors associated with intraoperativeadverse events. J Endourol 2008; 22:277-280
37. Tanriverdi O, Silay MS, Kadihasanoglu M, Aydin M, Kendirci M, Miroglu M. Revisiting
thepredictive factors for intra-operative complications of rigid ureteroscopy: a 15-year experience. Urol J 2012; 9:457-464.
38. Johnson DB, Pearle MS. Complications of ureteroscopy. Urol Clin North Am. 2004; 31:157-171.
39. Dybowsky B, Bres-Niewada E, Rzeszutko M, Tkaczyk A, Wozniac B, Wojcik M, et al. Risk factors for infectious complications after retrograde intrarenal surgery- a systematic review and narrative synthesis. Cent European J Urol. 2021; 74:437-445.
40. Kim DS, Yoo KH, Jeon SH, Lee SH. Risk factors of febrile urinary tract infections following retrograde intrarenal surgery for renal stones. Medicine (Baltimore) 2021; 100:e25182.
41. Masanobu Shigeta, Mutsuo Hayashi, Mikio Igawa; Fever after Extracorporeal Shock Wave Lithotripsy for Patients with Upper Urinary Tract Calculi Associated with Bacteriuria before Treatment. European Urology 1 February 1995; 27 (2): 121–123. https://doi.org/10.1159/000475141
42. Traxer O, Thomas A. Prospective evaluation and classification of ureteral wall injuries resulting from insertion of a ureteral access sheath during retrograde intrarenal surgery. J Urol 2013; 189:580‑4.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.